{"pmid":32422375,"title":"Do superspreaders generate new superspreaders? a hypothesis to explain the propagation pattern of COVID-19.","text":["Do superspreaders generate new superspreaders? a hypothesis to explain the propagation pattern of COVID-19.","The current global propagation of COVID-19 is heterogeneous, with slow transmission continuing in many countries, and exponential propagation in others, in which the time that took to begin this explosive spread varies greatly. It is proposed that this could be explained by cascading superspreading events, in which new infections caused by a superspreader are more likely to be highly infectious. The mechanism suggested for this is related to viral loads. Exposure to high viral loads may result in infections of high intensity, which exposes new cases to high viral loads, and so on. This notion is supported by experimental veterinary research.","Int J Infect Dis","Beldomenico, Pablo M","32422375"],"abstract":["The current global propagation of COVID-19 is heterogeneous, with slow transmission continuing in many countries, and exponential propagation in others, in which the time that took to begin this explosive spread varies greatly. It is proposed that this could be explained by cascading superspreading events, in which new infections caused by a superspreader are more likely to be highly infectious. The mechanism suggested for this is related to viral loads. Exposure to high viral loads may result in infections of high intensity, which exposes new cases to high viral loads, and so on. This notion is supported by experimental veterinary research."],"journal":"Int J Infect Dis","authors":["Beldomenico, Pablo M"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422375","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ijid.2020.05.025","keywords":["covid-19","sars-cov-2","epidemiology","propagation","superspreader","superspreading","transmission"],"topics":["Mechanism"],"weight":1,"_version_":1667159284557807617,"score":9.490897,"similar":[{"pmid":32187007,"title":"Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","text":["Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks.","Emerg Infect Dis","Frieden, Thomas R","Lee, Christopher T","32187007"],"abstract":["It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks."],"journal":"Emerg Infect Dis","authors":["Frieden, Thomas R","Lee, Christopher T"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32187007","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.3201/eid2606.200495","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","sses","behavioral factors","coronavirus","disease control","environmental factors","host factors","outbreaks","pathogen-specific factors","respiratory infections","response factors","severe acute respiratory syndrome coronavirus 2","superspreading events","viruses","zoonoses"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138492522987523,"score":230.79935},{"pmid":32215622,"pmcid":"PMC7184405","title":"Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility.","text":["Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility.","BACKGROUND: A physiological small animal model that resembles COVID-19 with low mortality is lacking. METHODS: Molecular docking on the binding between angiotensin-converting enzyme 2 (ACE2) of common laboratory mammals and the receptor-binding domain of the surface spike protein of SARS-CoV-2 suggested that the golden Syrian hamster is an option. Virus challenge, contact transmission, and passive immunoprophylaxis were performed. Serial organ tissues and blood were harvested for histopathology, viral load and titre, chemokine/cytokine assay, and neutralising antibody titre. RESULTS: The Syrian hamster could be consistently infected by SARS-CoV-2. Maximal clinical signs of rapid breathing, weight loss, histopathological changes from the initial exudative phase of diffuse alveolar damage with extensive apoptosis to the later proliferative phase of tissue repair, airway and intestinal involvement with virus nucleocapsid protein expression, high lung viral load, and spleen and lymphoid atrophy associated with marked cytokine activation were observed within the first week of virus challenge. The lung virus titre was between 105-107 TCID50/g. Challenged index hamsters consistently infected naive contact hamsters housed within the same cage, resulting in similar pathology but not weight loss. All infected hamsters recovered and developed mean serum neutralising antibody titre >/=1:427 fourteen days post-challenge. Immunoprophylaxis with early convalescent serum achieved significant decrease in lung viral load but not in lung pathology. No consistent non-synonymous adaptive mutation of the spike was found in viruses isolated from infected hamsters. CONCLUSIONS: Besides satisfying the Koch's postulates, this readily available hamster model is an important tool for studying transmission, pathogenesis, treatment, and vaccination against SARS-CoV-2.","Clin Infect Dis","Chan, Jasper Fuk-Woo","Zhang, Anna Jinxia","Yuan, Shuofeng","Poon, Vincent Kwok-Man","Chan, Chris Chung-Sing","Lee, Andrew Chak-Yiu","Chan, Wan-Mui","Fan, Zhimeng","Tsoi, Hoi-Wah","Wen, Lei","Liang, Ronghui","Cao, Jianli","Chen, Yanxia","Tang, Kaiming","Luo, Cuiting","Cai, Jian-Piao","Kok, Kin-Hang","Chu, Hin","Chan, Kwok-Hung","Sridhar, Siddharth","Chen, Zhiwei","Chen, Honglin","To, Kelvin Kai-Wang","Yuen, Kwok-Yung","32215622"],"abstract":["BACKGROUND: A physiological small animal model that resembles COVID-19 with low mortality is lacking. METHODS: Molecular docking on the binding between angiotensin-converting enzyme 2 (ACE2) of common laboratory mammals and the receptor-binding domain of the surface spike protein of SARS-CoV-2 suggested that the golden Syrian hamster is an option. Virus challenge, contact transmission, and passive immunoprophylaxis were performed. Serial organ tissues and blood were harvested for histopathology, viral load and titre, chemokine/cytokine assay, and neutralising antibody titre. RESULTS: The Syrian hamster could be consistently infected by SARS-CoV-2. Maximal clinical signs of rapid breathing, weight loss, histopathological changes from the initial exudative phase of diffuse alveolar damage with extensive apoptosis to the later proliferative phase of tissue repair, airway and intestinal involvement with virus nucleocapsid protein expression, high lung viral load, and spleen and lymphoid atrophy associated with marked cytokine activation were observed within the first week of virus challenge. The lung virus titre was between 105-107 TCID50/g. Challenged index hamsters consistently infected naive contact hamsters housed within the same cage, resulting in similar pathology but not weight loss. All infected hamsters recovered and developed mean serum neutralising antibody titre >/=1:427 fourteen days post-challenge. Immunoprophylaxis with early convalescent serum achieved significant decrease in lung viral load but not in lung pathology. No consistent non-synonymous adaptive mutation of the spike was found in viruses isolated from infected hamsters. CONCLUSIONS: Besides satisfying the Koch's postulates, this readily available hamster model is an important tool for studying transmission, pathogenesis, treatment, and vaccination against SARS-CoV-2."],"journal":"Clin Infect Dis","authors":["Chan, Jasper Fuk-Woo","Zhang, Anna Jinxia","Yuan, Shuofeng","Poon, Vincent Kwok-Man","Chan, Chris Chung-Sing","Lee, Andrew Chak-Yiu","Chan, Wan-Mui","Fan, Zhimeng","Tsoi, Hoi-Wah","Wen, Lei","Liang, Ronghui","Cao, Jianli","Chen, Yanxia","Tang, Kaiming","Luo, Cuiting","Cai, Jian-Piao","Kok, Kin-Hang","Chu, Hin","Chan, Kwok-Hung","Sridhar, Siddharth","Chen, Zhiwei","Chen, Honglin","To, Kelvin Kai-Wang","Yuen, Kwok-Yung"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32215622","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1093/cid/ciaa325","keywords":["covid-19","sars-cov-2","animal","coronavirus","transmission"],"locations":["Syrian","Syrian","Syrian"],"countries":["Syrian Arab Republic"],"countries_codes":["SYR|Syrian Arab Republic"],"topics":["Transmission","Mechanism"],"weight":1,"_version_":1666138490510770176,"score":132.90907},{"pmid":32473600,"title":"Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.","text":["Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.","Baricitinib, is an oral Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI)-algorithms, to be useful for COVID-19 infection via a proposed anti-cytokine effects and as an inhibitor of host cell viral propagation. We evaluated the in vitro pharmacology of baricitinib across relevant leukocyte subpopulations coupled to its in vivo pharmacokinetics and showed it inhibited signaling of cytokines implicated in COVID-19 infection. We validated the AI-predicted biochemical inhibitory effects of baricitinib on human numb-associated kinase (hNAK) members measuring nanomolar affinities for AAK1, BIKE, and GAK. Inhibition of NAKs led to reduced viral infectivity with baricitinib using human primary liver spheroids. These effects occurred at exposure levels seen clinically. In a case series of patients with bilateral COVID-19 pneumonia, baricitinib treatment was associated with clinical and radiologic recovery, a rapid decline in SARS-CoV-2 viral load, inflammatory markers, and IL-6 levels. Collectively, these data support further evaluation of the anti-cytokine and anti-viral activity of baricitinib and supports its assessment in randomized trials in hospitalized COVID-19 patients.","EMBO Mol Med","Stebbing, Justin","Krishnan, Venkatesh","de Bono, Stephanie","Ottaviani, Silvia","Casalini, Giacomo","Richardson, Peter J","Monteil, Vanessa","Lauschke, Volker M","Mirazimi, Ali","Youhanna, Sonia","Tan, Yee-Joo","Baldanti, Fausto","Sarasini, Antonella","Terres, Jorge A Ross","Nickoloff, Brian J","Higgs, Richard E","Rocha, Guilherme","Byers, Nicole L","Schlichting, Douglas E","Nirula, Ajay","Cardoso, Anabela","Corbellino, Mario","32473600"],"abstract":["Baricitinib, is an oral Janus kinase (JAK)1/JAK2 inhibitor approved for the treatment of rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI)-algorithms, to be useful for COVID-19 infection via a proposed anti-cytokine effects and as an inhibitor of host cell viral propagation. We evaluated the in vitro pharmacology of baricitinib across relevant leukocyte subpopulations coupled to its in vivo pharmacokinetics and showed it inhibited signaling of cytokines implicated in COVID-19 infection. We validated the AI-predicted biochemical inhibitory effects of baricitinib on human numb-associated kinase (hNAK) members measuring nanomolar affinities for AAK1, BIKE, and GAK. Inhibition of NAKs led to reduced viral infectivity with baricitinib using human primary liver spheroids. These effects occurred at exposure levels seen clinically. In a case series of patients with bilateral COVID-19 pneumonia, baricitinib treatment was associated with clinical and radiologic recovery, a rapid decline in SARS-CoV-2 viral load, inflammatory markers, and IL-6 levels. Collectively, these data support further evaluation of the anti-cytokine and anti-viral activity of baricitinib and supports its assessment in randomized trials in hospitalized COVID-19 patients."],"journal":"EMBO Mol Med","authors":["Stebbing, Justin","Krishnan, Venkatesh","de Bono, Stephanie","Ottaviani, Silvia","Casalini, Giacomo","Richardson, Peter J","Monteil, Vanessa","Lauschke, Volker M","Mirazimi, Ali","Youhanna, Sonia","Tan, Yee-Joo","Baldanti, Fausto","Sarasini, Antonella","Terres, Jorge A Ross","Nickoloff, Brian J","Higgs, Richard E","Rocha, Guilherme","Byers, Nicole L","Schlichting, Douglas E","Nirula, Ajay","Cardoso, Anabela","Corbellino, Mario"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473600","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.15252/emmm.202012697","keywords":["baricitinib","covid-19","anti-cytokine","anti-viral","case series"],"locations":["Janus"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668255193347653632,"score":132.76988},{"pmid":32447007,"title":"Severe air pollution links to higher mortality in COVID-19 patients: the \"double-hit\" hypothesis.","text":["Severe air pollution links to higher mortality in COVID-19 patients: the \"double-hit\" hypothesis.","OBJECTIVES: In areas of SARS-CoV-2 outbreak worldwide mean air pollutants concentrations vastly exceed the maximum limits. Chronic exposure to air pollutants have been associated with lung ACE-2 over-expression which is known to be the main receptor for SARS-coV2. The aim of this study was to analyse the relationship between air pollutants concentration (PM 2.5 and NO2) and COVID-19 outbreak, in terms of transmission, number of patients, severity of presentation and number of deaths. METHODS: COVID-19 cases, ICU admissions and mortality rate were correlated with severity of air pollution in the Italian regions. RESULTS: The highest number of COVID-19 cases were recorded in the most polluted regions with patients presenting with more severe forms of the disease requiring ICU admission. In these regions, mortality was two-fold higher than the other regions. CONCLUSIONS: From the data available we propose a \"double-hit hypothesis\": chronic exposure to PM 2.5 causes alveolar ACE-2 receptor overexpression. This may increase viral load in patients exposed to pollutants in turn depleting ACE-2 receptors and impairing host defences. High atmospheric NO2 may provide a second hit causing a severe form of SARS-CoV-19 in ACE-2 depleted lungs resulting in a worse outcome.","J Infect","Frontera, Antonio","Cianfanelli, Lorenzo","Vlachos, Kostantinos","Landoni, Giovanni","Cremona, George","32447007"],"abstract":["OBJECTIVES: In areas of SARS-CoV-2 outbreak worldwide mean air pollutants concentrations vastly exceed the maximum limits. Chronic exposure to air pollutants have been associated with lung ACE-2 over-expression which is known to be the main receptor for SARS-coV2. The aim of this study was to analyse the relationship between air pollutants concentration (PM 2.5 and NO2) and COVID-19 outbreak, in terms of transmission, number of patients, severity of presentation and number of deaths. METHODS: COVID-19 cases, ICU admissions and mortality rate were correlated with severity of air pollution in the Italian regions. RESULTS: The highest number of COVID-19 cases were recorded in the most polluted regions with patients presenting with more severe forms of the disease requiring ICU admission. In these regions, mortality was two-fold higher than the other regions. CONCLUSIONS: From the data available we propose a \"double-hit hypothesis\": chronic exposure to PM 2.5 causes alveolar ACE-2 receptor overexpression. This may increase viral load in patients exposed to pollutants in turn depleting ACE-2 receptors and impairing host defences. High atmospheric NO2 may provide a second hit causing a severe form of SARS-CoV-19 in ACE-2 depleted lungs resulting in a worse outcome."],"journal":"J Infect","authors":["Frontera, Antonio","Cianfanelli, Lorenzo","Vlachos, Kostantinos","Landoni, Giovanni","Cremona, George"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447007","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jinf.2020.05.031","locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1667698385868554240,"score":131.54683},{"pmid":32463076,"title":"Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies.","text":["Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies.","SARS-CoV-2 spread rapidly within months despite global public health strategies to curb transmission by testing symptomatic patients and encouraging social distancing. Here, we summarize rapidly emerging evidence highlighting transmission by asymptomatic and pre-symptomatic individuals. Viral load of asymptomatic carriers is comparable to symptomatic patients, viral shedding is highest before symptom onset suggesting high transmissibility before symptoms. Within universally tested subgroups, surprisingly high percentages of COVID-19 positive asymptomatic individuals were found. Asymptomatic transmission was reported in several clusters. A Wuhan study showed an alarming rate of intrahospital transmission, and several countries reported higher prevalence among healthcare workers than the general population. This raises concern that health workers could act as silent disease vectors. Therefore, current public health strategies relying solely on 'symptom onset' for infection identification need urgent reassessment. Extensive universal testing irrespective of symptoms may be considered with priority placed on groups with high frequency exposure to positive patients.","Clin Infect Dis","Huff, Hanalise V","Singh, Avantika","32463076"],"abstract":["SARS-CoV-2 spread rapidly within months despite global public health strategies to curb transmission by testing symptomatic patients and encouraging social distancing. Here, we summarize rapidly emerging evidence highlighting transmission by asymptomatic and pre-symptomatic individuals. Viral load of asymptomatic carriers is comparable to symptomatic patients, viral shedding is highest before symptom onset suggesting high transmissibility before symptoms. Within universally tested subgroups, surprisingly high percentages of COVID-19 positive asymptomatic individuals were found. Asymptomatic transmission was reported in several clusters. A Wuhan study showed an alarming rate of intrahospital transmission, and several countries reported higher prevalence among healthcare workers than the general population. This raises concern that health workers could act as silent disease vectors. Therefore, current public health strategies relying solely on 'symptom onset' for infection identification need urgent reassessment. Extensive universal testing irrespective of symptoms may be considered with priority placed on groups with high frequency exposure to positive patients."],"journal":"Clin Infect Dis","authors":["Huff, Hanalise V","Singh, Avantika"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463076","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/cid/ciaa654","keywords":["asymptomatic","covid-19","public health","sars-cov-2","transmission"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1668079521405861888,"score":130.06276}]}